Cargando…

Synthesis and Autoradiography of Novel F-18 Labeled Reversible Radioligands for Detection of Monoamine Oxidase B

[Image: see text] Monoamine oxidase B (MAO-B) is an important enzyme regulating the levels of monoaminergic neurotransmitters. Selective MAO-B inhibitors have been labeled with carbon-11 or fluorine-18 to visualize the localization of MAO-B in vivo by positron emission tomography (PET) and thereby h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nag, Sangram, Jia, Zhisheng, Svedberg, Marie, Jackson, Alex, Ahmad, Rabia, Luthra, Sajinder, Varnäs, Katarina, Farde, Lars, Halldin, Christer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747220/ https://www.ncbi.nlm.nih.gov/pubmed/33284012 http://dx.doi.org/10.1021/acschemneuro.0c00631

Ejemplares similares

PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023)

Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo
por: Varnäs, Katarina, et al.
Publicado: (2021)

Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020)

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography
por: Veldman, Emma R, et al.
Publicado: (2021)

Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [(18)F]Lu AF10628
por: Varnäs, Katarina, et al.
Publicado: (2016)

Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012)

Potential for imaging the high-affinity state of the 5-HT(1B) receptor: a comparison of three PET radioligands with differing intrinsic activity
por: Lindberg, Anton, et al.
Publicado: (2019)

Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP)
por: Nag, Sangram, et al.
Publicado: (2023)

The development of a GPR44 targeting radioligand [(11)C]AZ12204657 for in vivo assessment of beta cell mass
por: Jahan, Mahabuba, et al.
Publicado: (2018)

PET Imaging of VMAT2 with the Novel Radioligand [(18)F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [(11)C]DTBZ and [(18)F]FE-DTBZ
por: Nag, Sangram, et al.
Publicado: (2021)

“In‐loop” carbonylation—A simplified method for carbon‐11 labelling of drugs and radioligands
por: Ferrat, Mélodie, et al.
Publicado: (2020)

PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018)

Decreased 5‐HT(1A) binding in mild Alzheimer's disease—A positron emission tomography study
por: Mattsson, Patrik, et al.
Publicado: (2022)

Development of a Novel [(11)C]CO-Labeled Positron Emission Tomography Radioligand [(11)C]BIO-1819578 for the Detection of O-GlcNAcase Enzyme Activity
por: Nag, Sangram, et al.
Publicado: (2023)

Kinetic analysis of [(11)C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2013)

Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates
por: Schou, Magnus, et al.
Publicado: (2015)

[(11)C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET)
por: Gourand, Fabienne, et al.
Publicado: (2015)

Production of [(11)C]Carbon Labelled Flumazenil and L-Deprenyl Using the iMiDEV™ Automated Microfluidic Radiosynthesizer
por: Mallapura, Hemantha, et al.
Publicado: (2022)

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors
por: Legoabe, Lesetja J, et al.
Publicado: (2015)

Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
por: Yang, Kai-Chun, et al.
Publicado: (2016)

Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [(18)F]FE-PE2I-OH for Translational Dopamine Transporter Imaging
por: Schou, Magnus, et al.
Publicado: (2023)

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
por: Lemoine, Laetitia, et al.
Publicado: (2017)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans
por: Jucaite, Aurelija, et al.
Publicado: (2016)

Correction to “Development of (11)C-Labeled ASEM Analogues for Detection of Neuronal Nicotinic Acetylcholine Receptors (α7-nAChR)”
por: Nag, Sangram, et al.
Publicado: (2022)

Tranylcypromine specificity for monoamine oxidase is limited by promiscuous protein labelling and lysosomal trapping
por: Drechsel, Jonas, et al.
Publicado: (2020)

Development of (11)C-Labeled ASEM Analogues for the Detection of Neuronal Nicotinic Acetylcholine Receptors (α7-nAChR)
por: Nag, Sangram, et al.
Publicado: (2022)

Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor
por: Zarmouh, Najla O., et al.
Publicado: (2016)

Monoamine Oxidase A Hypomethylation in Obsessive-Compulsive Disorder: Reversibility By Successful Psychotherapy?
por: Schiele, Miriam A, et al.
Publicado: (2020)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020)

Autoradiography for biologists
por: Gahan, P B
Publicado: (1972)

The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
por: Zarmouh, Najla O., et al.
Publicado: (2017)

Test-retest reproducibility of [(11)C]-l-deprenyl-D(2) binding to MAO-B in the human brain
por: Arakawa, Ryosuke, et al.
Publicado: (2017)

3-Coumaranone derivatives as inhibitors of monoamine oxidase
por: Van Dyk, Adriaan S, et al.
Publicado: (2015)

Monoamine Oxidase B in Renal Cell Carcinoma
por: Hodorová, Ingrid, et al.
Publicado: (2018)

Cardiac monoamine oxidases: at the heart of mitochondrial dysfunction
por: Mialet-Perez, Jeanne, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qoggvek9e3a3o43vtm7dagvmkj